Thrombosis is initiated by tissue factor (TF), a coagulation cofactor/receptor expressed in the vessel wall, on myeloid cells, and on microparticles (MPs) with variable procoagulant activity. However, the molecular pathways that generate prothrombotic TF in vivo are poorly defined. The oxidoreductase protein disulfide isomerase (PDI) is thought to be involved in the activation of TF. Here, we found that in mouse myeloid cells, ATP-triggered signaling through purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7 receptor; encoded by P2rx7) induced activation (decryption) of TF procoagulant activity and promoted release of TF+ MPs from macrophages and SMCs. The generation of prothrombotic MPs required P2X7 receptor–dependent production of ROS leading to increased availability of solvent-accessible extracellular thiols. An antibody to PDI with antithrombotic activity in vivo attenuated the release of procoagulant MPs. In addition, P2rx7–/– mice were protected from TF-dependent FeCl3-induced carotid artery thrombosis. BM chimeras revealed that P2X7 receptor prothrombotic function was present in both hematopoietic and vessel wall compartments. In contrast, an alternative anti-PDI antibody showed activities consistent with cellular activation typically induced by P2X7 receptor signaling. This anti-PDI antibody restored TF-dependent thrombosis in P2rx7–/– mice. These data suggest that PDI regulates a critical P2X7 receptor–dependent signaling pathway that generates prothrombotic TF, defining a link between inflammation and thrombosis with potential implications for antithrombotic therapy.
Christian Furlan-Freguia, Patrizia Marchese, András Gruber, Zaverio M. Ruggeri, Wolfram Ruf
Title and authors | Publication | Year |
---|---|---|
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
Reema Jasuja, Freda H. Passam, Daniel R. Kennedy, Sarah H. Kim, Lotte van Hessem, Lin Lin, Sheryl R. Bowley, Sucharit S. Joshi, James R. Dilks, Bruce Furie, Barbara C. Furie, Robert Flaumenhaft |
Journal of Clinical Investigation | 2012 |
Ectonucleotide Triphosphate Diphosphohydrolase-1 (CD39) Mediates Resistance to Occlusive Arterial Thrombus Formation after Vascular Injury in Mice
ZM Huttinger, MW Milks, MS Nickoli, WL Aurand, LC Long, DG Wheeler, KM Dwyer, AJ d'Apice, SC Robson, PJ Cowan, RJ Gumina |
The American Journal of Pathology | 2012 |
Regulation of tissue factor coagulant activity on cell surfaces
LV Rao, UR Pendurthi |
Journal of Thrombosis and Haemostasis | 2012 |
Tissue Factor encryption and decryption: Facts and controversies
LV Rao, H Kothari, UR Pendurthi |
Thrombosis Research | 2012 |
Role of thiol pathways in TF procoagulant regulation
W Ruf |
Thrombosis Research | 2012 |
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling
C Reinhardt, M Bergentall, TU Greiner, F Schaffner, G Östergren-Lundén, LC Petersen, W Ruf, F Bäckhed |
Nature | 2012 |
A Common Missense Variant in the ATP Receptor P2X7 Is Associated with Reduced Risk of Cardiovascular Events
O Gidlöf, JG Smith, O Melander, H Lövkvist, B Hedblad, G Engström, P Nilsson, J Carlson, G Berglund, S Olsson, K Jood, C Jern, B Norrving, A Lindgren, D Erlinge |
PloS one | 2012 |
P2X7 regulation of macrophage tissue factor activity and microparticle generation
R Lee, JC Williams, N Mackman |
Journal of Thrombosis and Haemostasis | 2012 |